Simon Vyse
Impact in
-
- Lung Cancer Treatments and Mutations
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer therapeutics and mechanisms 3
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 2
- Chromatin Remodeling and Cancer 2
- Oncology 7
- Lung Cancer Research Studies 2
- Co-authors
- Paul H. Huang (13 shared papers)Aik Choon Tan (3 shared papers)Myles Lewis (4 shared papers)Timothy J. Vyse (4 shared papers)Andrew Jenks (3 shared papers)Adrian Shields (3 shared papers)Patrick Gordon (3 shared papers)Sebastian Boeltz (2 shared papers)
- Journals
- Cell Reports (2 papers)Pharmacogenomics and Personalized Medicine (1 paper)Human Molecular Genetics (1 paper)Signal Transduction and Targeted Therapy (1 paper)Oncotarget (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Simon Vyse
17 papers receiving 1.1k citations
Simon Vyse's Hit Papers
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 486
- Oncology 386
- Cancer Research 178
- Molecular Biology 502
- Immunology 113
Countries citing papers authored by Simon Vyse
This map shows the geographic impact of Simon Vyse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Vyse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Vyse more than expected).
Fields of papers citing papers by Simon Vyse
This network shows the impact of papers produced by Simon Vyse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Vyse. The network helps show where Simon Vyse may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Vyse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer Hit paper breakdown → | 2019 | 410 |
| 2 | 2019 | 257 | |
| 3 | 2018 | 91 | |
| 4 | 2015 | 84 | |
| 5 | 2016 | 42 | |
| 6 | 2017 | 36 | |
| 7 | 2016 | 34 | |
| 8 | 2016 | 30 | |
| 9 | 2016 | 30 | |
| 10 | 2017 | 26 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 21 | |
| 13 | 2016 | 20 | |
| 14 | 2021 | 17 | |
| 15 | 2015 | 15 | |
| 16 | 2017 | 13 | |
| 17 | 2017 | 12 |
About Simon Vyse
Simon Vyse is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Pathology and Forensic Medicine, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer therapeutics and mechanisms (3 papers), Ubiquitin and proteasome pathways (2 papers), Cancer Genomics and Diagnostics (2 papers), Galectins and Cancer Biology (2 papers), Lung Cancer Research Studies (2 papers), Protein Degradation and Inhibitors (2 papers) and Chromatin Remodeling and Cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (486 citations), Oncology (386 citations), Cancer Research (178 citations), Molecular Biology (502 citations) and Immunology (113 citations). Simon Vyse has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul H. Huang, Aik Choon Tan, Myles Lewis, Timothy J. Vyse, Andrew Jenks, Adrian Shields, Patrick Gordon, Sebastian Boeltz, Henning Walczak and Paul J. Lehner. Their work appears in journals such as Cell Reports, Pharmacogenomics and Personalized Medicine, Human Molecular Genetics, Signal Transduction and Targeted Therapy and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.